Alkermes (NASDAQ:ALKS) Given New $35.00 Price Target at Piper Sandler
Alkermes (NASDAQ:ALKS – Free Report) had its price objective decreased by Piper Sandler from $37.00 to $35.00 in a research note issued to investors on Friday morning, Benzinga reports. Piper Sandler currently has an overweight rating on the stock. ALKS has been the subject of several other reports. UBS Group started coverage on shares of […]
More Stories
Brunswick Bancorp (OTCMKTS:BRBW) and Republic Bancorp (NASDAQ:RBCAA) Head to Head Comparison
Republic Bancorp (NASDAQ:RBCAA – Get Free Report) and Brunswick Bancorp (OTCMKTS:BRBW – Get Free Report) are both small-cap finance companies,...
Great Valley Advisor Group Inc. Has $20.77 Million Holdings in Visa Inc. (NYSE:V)
Great Valley Advisor Group Inc. raised its stake in Visa Inc. (NYSE:V – Free Report) by 3.3% during the 3rd...
Camden National Bank Cuts Stock Holdings in The Home Depot, Inc. (NYSE:HD)
Camden National Bank trimmed its position in shares of The Home Depot, Inc. (NYSE:HD – Free Report) by 0.4% in...
Sysco Co. (NYSE:SYY) Shares Purchased by Leelyn Smith LLC
Leelyn Smith LLC boosted its stake in Sysco Co. (NYSE:SYY – Free Report) by 5.0% in the 3rd quarter, according...
Stonebrook Private Inc. Lowers Position in Johnson & Johnson (NYSE:JNJ)
Stonebrook Private Inc. trimmed its stake in Johnson & Johnson (NYSE:JNJ – Free Report) by 0.5% during the 3rd quarter,...
49 Wealth Management LLC Grows Stock Position in Pfizer Inc. (NYSE:PFE)
49 Wealth Management LLC increased its position in Pfizer Inc. (NYSE:PFE – Free Report) by 7.4% in the 3rd quarter,...